Pharma’s Ghost Labs Find New Life
Pharma’s Ghost Labs Find New Life
Finding new tenants for former drug development sites isn’t always easy. But a new, thriving industry has materialized to do just that.
Pharma’s Ghost Labs Find New Life
Pharma’s Ghost Labs Find New Life

Finding new tenants for former drug development sites isn’t always easy. But a new, thriving industry has materialized to do just that.

Finding new tenants for former drug development sites isn’t always easy. But a new, thriving industry has materialized to do just that.

biobusiness
Antidepressant Approvals Could Herald New Era in Psychiatric Drugs
Antidepressant Approvals Could Herald New Era in Psychiatric Drugs
Bianca Nogrady | Oct 1, 2019
The FDA has given the green light to the first major new classes of antidepressant therapies in decades, opening up new avenues for therapeutic development.
Biotechs Race to Develop Stem Cell Treatments for Diabetes
Biotechs Race to Develop Stem Cell Treatments for Diabetes
Eric Bender | Jul 15, 2019
Insulin-producing cells grown in the lab could offer a functional cure for the disease.
Artificial Intelligence Shakes Up Drug Discovery
Artificial Intelligence Shakes Up Drug Discovery
Bianca Nogrady | May 1, 2019
The pharmaceutical industry is looking to machine learning to overcome complex challenges in drug development.
Scientists Take Aim at Disease-Causing RNAs Using Small-Molecule Drugs
Scientists Take Aim at Disease-Causing RNAs Using Small-Molecule Drugs
Claire Asher | Apr 1, 2019
Renewed interest from the biotech industry sparks hope for drugging the nucleic acid to treat cancer and other conditions.
UC Berkeley Team to Be Awarded CRISPR Patent
UC Berkeley Team to Be Awarded CRISPR Patent
Kerry Grens | Feb 11, 2019
The group had argued that a patent given to the Broad Institute overlapped with this one.
Companies Use CRISPR to Improve Crops
Companies Use CRISPR to Improve Crops
Ashley P. Taylor | Feb 1, 2019
The agritech industry is editing plant genomes to feed a growing population, expand the produce aisle, and make tastier, more convenient food products.
Illumina to Buy Pacific Biosciences for $1.2 Billion
Illumina to Buy Pacific Biosciences for $1.2 Billion
Kerry Grens | Nov 6, 2018
The purchase adds long-read sequencing to Illumina’s portfolio.
The UK Pharmaceutical Industry Braces for Brexit
The UK Pharmaceutical Industry Braces for Brexit
Diana Kwon | Oct 12, 2018
As Britain’s departure date from the European Union approaches, drugmakers are preparing for potential changes to regulatory procedures and border controls.
Startups Plan the Health Data Gold Rush
Startups Plan the Health Data Gold Rush
Shawna Williams | Oct 1, 2018
Companies are building platforms based on blockchain technology to let individuals control and directly profit from their genomic and medical information.